Riskpilot← Back to searchSign inGet full accessNosturiklinikka Oy
OYActiveY-tunnus 3106851-8Nybyntie 74Repair and maintenance of motor vehicles · NACE 9531Est. 20199 employees
Revenue 2024
EUR 2,2M
+2% vs 2023
EBITDA margin
23.0%
+39% vs 2023
Equity ratio
74.1%
Financial strength
Net profit 2024
EUR 390K
+41% vs 2023
| Revenue | EUR 2,2M | +2% |
| EBITDA | EUR 516K | +39% |
| Net profit | EUR 390K | +41% |
| Total assets | EUR 1,1M | -99% |
| Equity | EUR 798K | -98% |
| Employees | 9 | — |
Legal name
Nosturiklinikka Oy
Y-tunnus number
3106851-8
Legal form
Osakeyhtiö
NACE code
9531 · Repair and maintenance of motor vehicles
Founded
20. joulukuuta 2019
Share capital
EUR 0
Employees
9 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Raskaan kaluston korjaus ja huolto
Address
Nybyntie 74
Phone
+3580503681105
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 617 | 1 335 | 1 810 | 2 212 | 2 249 |
| Staff expenses | −252 | −510 | −494 | −602 | −551 |
| EBITDA | 45 | 58 | 266 | 372 | 516 |
| Depreciation & amort. | −34 | −36 | −35 | −24 | −19 |
| EBIT | 11 | 22 | 231 | 348 | 497 |
| Net financials | −7 | −8 | −6 | −3 | −4 |
| Profit before tax | 4 | 14 | 225 | 345 | 493 |
| Tax | 1 | 3 | 45 | 69 | 103 |
| Net profit | 3 | 12 | 180 | 276 | 390 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 400 | 405 | 554 | 83 081 | 1 078 |
| Equity | 23 | 35 | 215 | 46 551 | 798 |
| Long-term debt | 196 | 104 | 63 | 1 717 | 0 |
| Short-term debt | 180 | 266 | 276 | 34 813 | 279 |
| Total debt | 377 | 370 | 339 | 36 530 | 279 |
EBITDA margin
23.0%
This company
15.8%
Market median
+46% vs market
20202024
Equity ratio
74.1%
This company
38.2%
Market median
+94% vs market
20202024
Return on equity
48.9%
This company
18.4%
Market median
+166% vs market
20202024
Net profit margin
17.3%
This company
8.1%
Market median
+114% vs market
20202024
Asset turnover
2.09×
This company
1.12×
Market median
+87% vs market
20202024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2019-12-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JJ Chief Executive Officer | Chief Executive Officer | 2021 |
JM Deputy Member | Deputy Member | 2022 |
| Former (1) | ||
SJ Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2019 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairperson | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nostosa Oy
Nosturiklinikka Oy Board members of Nosturiklinikka Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jorma Jaakko Juhani Hellberg | Chief Executive Officer | 0 companies |
| Janica Manninen | Deputy Member | 0 companies |
| Saku Juhani Riekki | Deputy Chief Executive Officer | 0 companies |
| Topi Johannes Rimpiläinen | Chairperson | 0 companies |